ID
AGN

Integral Derivatives’s Allergan Inc AGN Stock Holding History

Integral Derivatives’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,200
Closed -$392K – 1719
2014
Q3 		$392K Sell
2,200
-2,800
-56% -$465K 0.01% 1040
2014
Q2 		$846K Buy
5,000
+2,800
+127% +$436K 0.01% 753
2014
Q1 		$273K Sell
2,200
-17,800
-89% -$2.17M 0.01% 1091
2013
Q4 		$2.22M Buy
+20,000
New +$1.91M 0.03% 450

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Integral Derivatives's AGN Position: Q1 2014 in Review

Integral Derivatives sold out of Allergan Inc (AGN) in Q1 2014, closing a stake of 25,384 shares — an estimated $3.09M sold.

Integral Derivatives first reported a position in AGN in Q4 2013 and held it in 1 quarter. The position peaked at $2.82M in Q4 2013. 733 funds tracked by Wall St. Rank hold AGN as of Q1 2014.

  • Integral Derivatives reported no remaining Allergan Inc position as of Q1 2014 after selling out during the quarter.
  • Integral Derivatives sold 25,384 Allergan Inc shares in Q1 2014, an estimated $3.09M.
  • Integral Derivatives first reported a position in Allergan Inc in Q4 2013 and held it in 1 quarter.
  • Integral Derivatives's Allergan Inc position peaked at $2.82M in Q4 2013.
  • 733 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2014.

Based on Integral Derivatives's 13F filing for Q1 2014, filed 2 May 2014.